Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Antonella Castagna

Showing results (381-390 of 467) with videos related to

Pageof 47
Sort By:
Plos One|October 14, 2020
Residual clinical damage after COVID-19: A retrospective and prospective observational cohort studyRebecca De Lorenzo, Caterina Conte, Chiara Lanzani, et al.
AIDS (London, England)|November 8, 2017
Where is the greatest impact of uncontrolled HIV infection on AIDS and non-AIDS events in HIV?Amanda Mocroft, Kamilla Laut, Peter Reiss, et al.
The New England Journal of Medicine|May 11, 2022
Capsid Inhibition with Lenacapavir in Multidrug-Resistant HIV-1 InfectionSorana Segal-Maurer, Edwin DeJesus, Hans-Jurgen Stellbrink, et al.
The European Respiratory Journal|February 20, 2025
Incident tuberculosis in people with HIV across Europe from 2012-2022: incidence rates, risk factors, and regional differences in a multicentre cohort studyChristian Kraef, Ashley Roen, Daria Podlekareva, et al.
Echocardiography (Mount Kisco, N.Y.)|October 21, 2021
Subclinical myocardial dysfunction in patients recovered from COVID-19Leonardo Italia, Giacomo Ingallina, Antonio Napolano, et al.
Plant, Cell & Environment|August 10, 2017
Environmental plasticity of Pinot noir grapevine leaves: A trans-European study of morphological and biochemical changes along a 1,500-km latitudinal climatic gradientAntonella Castagna, Kristóf Csepregi, Susanne Neugart, et al.
The Journal of Antimicrobial Chemotherapy|April 19, 2018
Atazanavir/ritonavir with lamivudine as maintenance therapy in virologically suppressed HIV-infected patients: 96 week outcomes of a randomized trialMassimiliano Fabbiani, Roberta Gagliardini, Nicoletta Ciccarelli, et al.
Andrology|November 2, 2022
Combined plasma levels of IL-10 and testosterone, but not soluble HLA-G5, predict the risk of death in COVID-19 patientsGiada Amodio, Paolo Capogrosso, Marina Pontillo, et al.
The Lancet. HIV|October 31, 2020
Safety and efficacy of the HIV-1 attachment inhibitor prodrug fostemsavir in heavily treatment-experienced individuals: week 96 results of the phase 3 BRIGHTE studyMax Lataillade, Jacob P Lalezari, Michael Kozal, et al.
Andrology|October 17, 2022
Testosterone in males with COVID-19: a 12-month cohort studyAndrea Salonia, Marina Pontillo, Paolo Capogrosso, et al.
Pageof 47

Showing results (381-390 of 467) with videos related to

Sort By:
Pageof 47
Plos One|October 14, 2020
Residual clinical damage after COVID-19: A retrospective and prospective observational cohort studyRebecca De Lorenzo, Caterina Conte, Chiara Lanzani, et al.
AIDS (London, England)|November 8, 2017
Where is the greatest impact of uncontrolled HIV infection on AIDS and non-AIDS events in HIV?Amanda Mocroft, Kamilla Laut, Peter Reiss, et al.
The New England Journal of Medicine|May 11, 2022
Capsid Inhibition with Lenacapavir in Multidrug-Resistant HIV-1 InfectionSorana Segal-Maurer, Edwin DeJesus, Hans-Jurgen Stellbrink, et al.
The European Respiratory Journal|February 20, 2025
Incident tuberculosis in people with HIV across Europe from 2012-2022: incidence rates, risk factors, and regional differences in a multicentre cohort studyChristian Kraef, Ashley Roen, Daria Podlekareva, et al.
Echocardiography (Mount Kisco, N.Y.)|October 21, 2021
Subclinical myocardial dysfunction in patients recovered from COVID-19Leonardo Italia, Giacomo Ingallina, Antonio Napolano, et al.
Plant, Cell & Environment|August 10, 2017
Environmental plasticity of Pinot noir grapevine leaves: A trans-European study of morphological and biochemical changes along a 1,500-km latitudinal climatic gradientAntonella Castagna, Kristóf Csepregi, Susanne Neugart, et al.
The Journal of Antimicrobial Chemotherapy|April 19, 2018
Atazanavir/ritonavir with lamivudine as maintenance therapy in virologically suppressed HIV-infected patients: 96 week outcomes of a randomized trialMassimiliano Fabbiani, Roberta Gagliardini, Nicoletta Ciccarelli, et al.
Andrology|November 2, 2022
Combined plasma levels of IL-10 and testosterone, but not soluble HLA-G5, predict the risk of death in COVID-19 patientsGiada Amodio, Paolo Capogrosso, Marina Pontillo, et al.
The Lancet. HIV|October 31, 2020
Safety and efficacy of the HIV-1 attachment inhibitor prodrug fostemsavir in heavily treatment-experienced individuals: week 96 results of the phase 3 BRIGHTE studyMax Lataillade, Jacob P Lalezari, Michael Kozal, et al.
Andrology|October 17, 2022
Testosterone in males with COVID-19: a 12-month cohort studyAndrea Salonia, Marina Pontillo, Paolo Capogrosso, et al.
Pageof 47